Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Lab Invest. 2013 Apr 22;93(6):711–719. doi: 10.1038/labinvest.2013.62

Table 1.

Primary antibodies and conditions for immunohistochemistry

Marker Source Antibody Identifier Dilution Conditions
AE1/AE3 Novus Biologicals Cat#NB600-1322 1:40 HIER, citrate buffer (pH 6.0)
p63 Neomarkers Company Cat#MS-1081-P 1:200 HIER, citrate buffer (pH 6.0)
CK5/6 Dako Cat#M7237 1:100 HIER, citrate buffer (pH 6.0)
EGFR Abcam Cat#ab2430 1:100 HIER, citrate buffer (pH 6.0)
pEGFR Abcam Cat#ab40815 1:500 HIER, citrate buffer (pH 6.0)
GFAP Abcam Cat#ab16997 1:100 HIER, citrate buffer (pH 6.0)
cKIT Dako Cat#A4502 1:100 HIER, citrate buffer (pH 6.0)
S100 Dako Cat#Z0311 1:4000 HIER, citrate buffer (pH 6.0)
alpha-SMA Sigma Cat#A2547 1:2000 None